WASHINGTON, Dec 29 (Reuters) – The US Food and Drug Administration failed to follow its own internal guidelines and practices during Biogen’s approval process. (BIIB.O) Aduhelm, the Alzheimer’s drug, was …
WASHINGTON, Dec 29 (Reuters) – The US Food and Drug Administration failed to follow its own internal guidelines and practices during Biogen’s approval process. (BIIB.O) Aduhelm, the Alzheimer’s drug, was …